David Kraemer

David Kraemer is a capital formation, business development, and investment executive with more years of experience across institutional consulting, private wealth, private markets, and life sciences and MedTech innovation. He has held roles at Merrill Lynch in New York and Wilshire Associates in Pittsburgh and Santa Monica, before eventually founding 10‖2 Capital Partners, a boutique advisory firm supporting biotech, MedTech, DeepTech, and healthcare ventures. His representative mandates include advisory work for a $100M first-time global VC fund led by executives from Venrock, McKesson, and Gilead; a HealthTech/AI-focused Fund III with portfolio companies such as VIOME and Deep Instinct; and private companies advancing FDA-cleared and AI-driven medical technologies later acquired by strategics. Currently completing his Master of Biotechnology Enterprise & Entrepreneurship (MBEE) at The Johns Hopkins University, David is focused on bringing this combined expertise into a full-time leadership role within a growing biotech, MedTech, investment fund, or the innovation arm of an integrated healthcare organization.